Drug · DIN 02477181
ESCITALOPRAM
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since April 26, 2023.
- Drug Identification Number (DIN)
- 02477181
- Company (DIN owner)
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Escitalopram N06AB10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ESCITALOPRAM (ESCITALOPRAM OXALATE) | 15 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 26, 2023: NOC 30591Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Product Name Change
- June 13, 2018: NOC 20980Abbreviated New Drug Submission (ANDS) · Administrative licensing agreement between two companies
Other DINs named ESCITALOPRAM
- DIN 02424401 · Marketed
- DIN 02424428 · Marketed
- DIN 02429039 · Marketed
- DIN 02429047 · Marketed
- DIN 02429780 · Marketed
- DIN 02429799 · Marketed
- DIN 02430118 · Marketed
- DIN 02430126 · Marketed
- DIN 02438496 · Cancelled Pre Market
- DIN 02438518 · Cancelled Pre Market
- DIN 02466058 · Approved
- DIN 02466066 · Approved
- DIN 02477203 · Approved
- DIN 02489171 · Cancelled Post Market
- DIN 02489201 · Cancelled Post Market
- DIN 02506602 · Cancelled Pre Market
- DIN 02506610 · Cancelled Pre Market
- DIN 02506629 · Cancelled Pre Market
- DIN 02506637 · Cancelled Pre Market